BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Randox Release: Multi-Analyte Immunoassay Control with Assayed Values for 54 Analytes Including Vitamin D


12/22/2011 8:30:15 AM

Crumlin, UK , December 22, 2011 / B3C newswire / - As the demand for Vitamin D testing increases so does the demand for accurate and reliable test results. The Randox Acusera immunoassay premium plus control is designed to monitor the accuracy and precision of up to 54 analytes including 25-OH Vitamin D and 1-25(OH)2 Vitamin D. In addition to this instrument specific target values are provided for a wide range of fertility hormones, thyroid hormones, steroid hormones, kidney function tests, therapeutic drugs and tumour markers. The inclusion of routinely run tumour markers and parameters such as intact PTH allows you to simplify your quality control practices by dramatically reducing the number of controls used in your laboratory with the added benefit of cost and time savings.

Three levels of control are available covering the complete clinical range. In the level 1 control Ferritin, vitamin B12 and TSH are present at clinically significant levels further eliminating the need to purchase additional and often expensive low level controls.

With a shelf life of up to four years from the date of manufacture; our immunoassay premium plus control is suitable for long term QC monitoring and can significantly reduce the costs and problems associated with changing lot numbers.

Like all our immunoassay controls, our immunoassay premium plus control is manufactured from 100% human materials meaning it won’t interfere with antibody based tests or cause problems when changing batch of reagent.

As a true supplier of third party controls Randox products provide an unbiased, independent assessment of performance. Our unique value assignment process employs over 20,000 independent laboratories worldwide making our controls the most accurately assigned on the market. With 30 years experience in quality control; excellent choice, stability and most importantly performance is guaranteed.

Vitamin D can also be found in our RIQAS Immunoassay EQA programme. RIQAS (Randox International Quality Assessment Scheme) is the world’s largest global EQA scheme with more than 20,000 participants in over 100 countries worldwide. Our extensive immunoassay programme contains 54 analytes in total including Vitamin D however participants can choose to monitor a reduced number of analytes. Like our immunoassay controls all samples are 100% human in origin meaning they won’t interfere with antibody based tests.

About Randox

Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.

For more information contact us at marketing@randox.com


Read at BioSpace.com

Randox
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->